Modeling a Dielectrophoresis-based Application to Personalize Cancer Treatment and Increase Recovery Rates
Modern bio-medicine practitioners are showing increasing interest in dielectrophoresis (DEP) because of the recent progress in the development of micro-electrodes. DEP gives you control of the trajectories of bio-particles (tumor cells, white blood cells, bio-markers, etc.), resulting in efficient separation and/or selective trapping with low particle damage.
View this on-demand webinar and learn how using Ansys simulation as a virtual prototyping tool can shorten the path to commercialization of this technology and make it more robust and repeatable. We will demonstrate how to explore and optimize electrode design and operating conditions to adapt them to the specific properties of bio-particles.